10 maj: Indre værdi af SmallCap Danmark A/S er opgjort til 10,6 kr. pr. a..
10 maj: Danske Bank udnævner ny administrerende direktør
10-05-2019 08:10:22

Ambu A/S: Ambu appoints new CEO

Ambu’s board of directors has appointed Juan-José Gonzalez as the new CEO, effective May 15, 2019, to replace Lars Marcher who resigns from his position.

Jens Bager, Chairman of the Ambu Board of Directors, comments, “During Lars Marchers' leadership, Ambu has developed a strong and broad platform of medtech products, which have formed the basis for impressive growth. I and the rest of the board would like to thank Lars very much for his contribution to this remarkable decade in Ambu’s history. At the same time, I am pleased to have secured Juan-José Gonzalez, whom I am confident will be an excellent successor and the right choice to lead Ambu into its next growth phase.

Juan-José Gonzalez is an engineer and MBA graduate and has held a number of senior positions in the US healthcare group Johnson & Johnson for the past 12 years. Most recently, he has been President for the activities of the subsidiary DePuy Synthes in the US, with a turnover of DKK 33bn and more than 5,000 employees. DePuy Synthes is one of the world's leading manufacturers of orthopedic and neurosurgical products. Prior to joining Johnson & Johnson in 2007, Juan-José Gonzalez was a commercial director of the pharmaceutical company Pfizer, responsible for Europe, Africa and the Middle East, and for five years employed by the global consulting firm McKinsey & Company. Juan-José Gonzalez is 46 years old, an American citizen and relocates from the United States to Denmark with his wife and their two children.

"Ambu is facing a major international breakthrough with a number of high-tech products in the business area of Visualization with a broad program of single-use endoscopes in the USA and the rest of the world. With Juan-José Gonzalez as CEO, we ensure that Ambu also has the necessary global experience to execute the announced strategy and ensure the succesful commercialization of our product launches,” says Jens Bager.

Juan-José Gonzalez looks forward to joining Ambu as the new CEO. “The strength of Ambu is the company’s ability to deliver on differentiated innovation. Its pioneering of single-use endoscopy is a great example of Ambu’s focus on innovation. I am deeply committed to the plan to continue Ambu’s legacy of bringing innovative products to patients around the world. With Ambu’s recent launches, strong pipeline and committed people, I am very confident about our future." says Juan-José Gonzalez.

Financial expectations

The replacement of the CEO does not change the announced financial expectations for 2018/19 – except for the one-off costs listed below – or the financial targets for 2020 as outlined in the Big Five strategy. Planned product launches up to the end of the financial year 2019/20 and Ambu´s program for the upcomming DDW congress in San Diego on 18-21 May 2019 is thus unaffected by this.

In relation to Lars Marcher's resignation, there will be one-off costs of approx. DKK 38m, which for accounting purposes will be recognized in the income statement as Special items. The costs relates, among other things, to salary during the period of notice and the costs of the remaining value of already granted share options calculated according to the Black Scholes formula. These Black Scholes costs amounts to DKK 16m which so far has been distributed over the allocation period of the share options, but will now be fully charged to the income statement in the 3rd quarter of the financial year 2018/19 as a direct consequence of Lars Marcher's resignation.Before special items as referred above the financial expectations for the financial year 2018/19 are unchanged compared to the guidance provided in the interim report for our 2nd quarter on May 1, 2019, and can hereafter be summarized as:

  • Organic growth of approx. 15-16%.
  • EBIT margin before special items of approx. 22-24%.
  • Free cash flow of approx. DKK 400-475m.

Contact

For further information please contact:

Jens Bager, Chairman of the Board, tel. +45 2299 0304

Michael Højgaard, CFO, tel. +45 4030 4349

Press Inquiries: Morten Huse Eikrem-Jeppesen, PressConnect, tel. +45 5385 0770

Attachment

logo.png

Relateret indhold
24 maj - 
Fredagens aktier: Mærsk faldt efter regnskab i ellers p..
24 maj - 
Amerikansk hedgefund øger shortposition på Abmu til 288..
23 maj - 
Torsdagens aktier: Mærsk til tælling inden kvartalstal ..
Relateret debat
16:08 - 
Don Gonzalez er åbenbart mødt på arbejde. https://www.l..
11:09 - 
Shorterne øger - det bliver ikke sjovt - det er rent pa..
09:51 - 
Ja Vietnam tror jeg det er ulovligt. Ellers har det vær..
Del

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
18 maj
AMBU-B
Cook Medical er en førende amerikansk medicovirksomhed med en omsætning på ca. 2 mia. usd og aktivit..
14
19 maj
AMBU-B
Et samarbejde med Cook Medical er en positiv nyhed. Cook Medical ligger i Bjæverskov (Køge), og har ..
10
24 maj
AMBU-B
Så fucking træt af det lort! Forpulede shortere
6
24 maj
AMBU-B
At det skal koste næste 100 kr i nedgang at skifte direktør med de rette kompetancer giver jo ikke m..
5
19 maj
AMBU-B
Ak folkens, Ambu er snart i 200 igen. Vent og se.
5
23 maj
AMBU-B
Har også taget chancen og øget i aktien, kan ikke se grunden til at den er faldet som den er pga dir..
4
22 maj
AMBU-B
Igen et bette nøk. Man tror jo dårligt sine gamle øjne. Er der ved at komme dun på vingerne ?   :-))
4
20 maj
AMBU-B
Ambu er meget over solgt pga hedgefondenes massive shorting angreb. PS har ikke aktien pga for mange..
4
19 maj
AMBU-B
Rigtig god nyhed fra Ambu, samt et særdeles positivt skridt med hensyn til produktlansering ef engan..
4
24 maj
AMBU-B
romoe er ved at forlade fra juliet hvis kursen holdes under 110 fra nu af, køb ikke før den kan hold..
3

Lars Christensens Verden - Episode 19: The Numbers Game - Tænk som en baseballtræner og find de mest attraktive aktier

24-05-2019 06:00:00
I denne episode er Maj Invests aktiechef Kura Kara og tidligere landholdsspiller og professionel basketballspiller Jens Laulund gæster i studiet til en samtale om, hvordan kvantitative analytiske metoder har vundet indpas i professionel holdsport - særligt i USA - og hvordan disse analysemetoder, der i stigende grad anvendes i  f.eks.baseball og basketball, kan lære os meget om investeringsstrateg..

Snabe køber aktier for lige under 1 mio. kr.

24-05-2019 16:07:03
Bestyrelsesformand i A.P. Møller - Mærsk Jim Hagemann Snabe har spenderet en lille million kr. på køb af aktier i firmaet.Snabe har helt præcist købt 144 stk. A-aktier i firmaet til en kurs på 6925 kr. og en samlet kursværdi af 997.200 kr.Mærsk-aktierne er fredag under pres efter selskabets regnskab for første kvartal, der blev offentliggjort fredag før børsåbningen.Mærsks A-aktie ligger kl. 16 fr..

Amerikansk hedgefund øger shortposition på Abmu til 288 mio.

24-05-2019 15:10:00
Eminence Capital har øget sin shortposition i Ambu og har nu shortet 1,21 pct. af den samlede aktiekapital i biotekselskabet mod tidligere 1,03 pct.Det fremgår fredag eftermiddag af en indberetning til Finanstilsynet. Ændringen i positionen er foretaget torsdag, fremgår det af meddelelsen.At gå kort i en aktie er at spekulere i et kursfald. Det sker ved, at spekulanten låner aktier i et selskab, s..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vindparkejer undersøger ny hændelse: Endnu en GE-mølle kollapset i USA
2
SAS/Pareto: Skærer mere end en fjerdel af kursmålet inden regnskab

Relaterede aktiekurser

Ambu A/S 107,55 -6,8% Fald i aktiekurs

Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
25. maj 2019 17:04:22
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190514.2 - EUROWEB2 - 2019-05-25 17:04:22 - 2019-05-25 17:04:22 - 1 - Website: OKAY